What GLP‑1 Drugs ACTUALLY Do (Beyond Appetite) | Ozempic, Wegovy, Mounjaro

GLP‑1 medications are not “just appetite suppressants.” They act on nearly every major organ in your body. This video explains the real science behind semaglutide (Ozempic, Wegovy) and tirzepatide (Mounjaro, Zepbound) so you understand exactly what they do and why physicians are using them for far more than weight loss. Learn more about metabolic and bariatric surgery in Miami: https://www.delaCruzMunoz.com Dr. Nestor de la Cruz‑Muñoz is a Metabolic and Bariatric Surgeon in Miami specializing in advanced minimally invasive and robotic procedures. GLP‑1 medications affect the brain, pancreas, stomach, heart, kidneys, liver, inflammation pathways, and more. In this video, we break down the mechanisms, the major clinical trials, the benefits beyond weight loss, and the emerging research that is reshaping metabolic medicine. We also cover side effects, misconceptions, and what patients should expect when starting therapy. CHAPTERS Introduction The Biggest Misconception Brain: Resetting Hunger Signals Pancreas: Smarter Insulin Release Insulin Sensitivity Before Weight Loss Stomach: Slowing Gastric Emptying Heart Protection (LEADER, SELECT, SOUL Trials) Heart Failure Benefits Kidney Protection (FLOW Trial) Liver: Treating Fatty Liver Disease (MASH) Inflammation Cholesterol and Triglycerides Sleep Apnea Diabetes Prevention Emerging Research (Alzheimer’s, Addiction, PCOS) Side Effects and What to Expect The Bottom Line KEY TAKEAWAYS • GLP‑1 drugs reduce heart attack, stroke, and cardiovascular death by 14–26 percent • Improve insulin sensitivity within two weeks, before weight loss occurs • Semaglutide reduced serious kidney outcomes by 24 percent (FLOW trial) • FDA‑approved for MASH (fatty liver disease with scarring) • Tirzepatide FDA‑approved for obstructive sleep apnea • Lower blood pressure, cholesterol, triglycerides, and inflammation • Being studied for Alzheimer’s, Parkinson’s, addiction, and PCOS DISCLAIMER This video is for educational purposes only and is not medical advice. Always consult your physician before starting or changing any medication. HASHTAGS #GLP1 #Ozempic #Wegovy #Mounjaro #Zepbound #Semaglutide #Tirzepatide #WeightLoss #Type2Diabetes #InsulinResistance #HeartHealth #KidneyDisease #FattyLiver #MASH #MetabolicHealth #DoctorExplains #MedicalScience #Obesity